Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Bailing Pharmaceutical is a Chinese pharmaceutical company primarily known for its production and distribution of traditional Chinese medicine (TCM) and modern health products, most notably those derived from Cordyceps sinensis. The company is a key subsidiary of Huadong Medicine, one of China's leading pharmaceutical manufacturers. Its flagship product, Bailing Capsules, is widely used in China for treating chronic kidney disease and respiratory conditions by modulating the immune system. Beyond its core TCM portfolio, the company is involved in the broader pharmaceutical supply chain, including manufacturing and commercialization of various therapeutic agents. Zhejiang Bailing Pharmaceutical plays a critical role in Huadong Medicine's strategy to integrate traditional medicinal wisdom with modern clinical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Bailing Pharmaceutical.